Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of 89bio, Inc. (ETNB)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of 89bio, Inc. since year 2005.
Table 2 shows the detailed insider transactions of 89bio, Inc. since 2005.
The reporting company's ticker symbol is ETNB. The reporting company's CIK number is 1785173.
The total value of stock buying since 2005 is $73,500,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-11||Pontifax Late Stage Fund L.p. (10% Owner)||Buy||250,000||16.00||4,000,000|
|2019-11-11||Naschitz Anat (Director)||Buy||837,500||16.00||13,400,000|
|2019-11-11||Grunberg Gregory (Director)||Buy||575,000||16.00||9,200,000|
|2019-11-11||Orbimed Israel Gp Ii, L.p. (Director)||Buy||837,500||16.00||13,400,000|
|2019-11-11||Shah Rajeev M.||Buy||1,500,000||16.00||24,000,000|
|2019-11-11||Hayden Michael R (Director)||Buy||18,750||16.00||300,000|
|2019-11-11||Enright Patrick G (10% Owner)||Buy||575,000||16.00||9,200,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ETNB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of 89bio, Inc. (symbol ETNB, CIK number 1785173) see the Securities and Exchange Commission (SEC) website.